Experimental gene therapy successful in certain lymphomas and leukemia
Study results of CD19-directed chimeric antigen receptor (CAR) therapy using the Sleeping Beauty non-viral transduction system to modify T cells has demonstrated further promise in patients with advanced hematologic malignancies.
Dec 8, 2014
0
0